Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rise in government funding grants for clinical trials
3.2.1.2 Growing demand for outsourcing clinical trials to CROs
3.2.1.3 Increasing adoption of software solutions in clinical trials
3.2.1.4 Increasing R&D expenditure across the globe
3.2.2 Industry pitfalls and challenges
3.2.2.1 High implantation cost
3.2.2.2 Low adoption and lack of awareness pertaining to eClinical solutions in developing countries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Software landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Solution, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Randomization and trial supply management
5.3 Clinical data management system (CDMS)
5.4 Clinical trial management system (CTMS)
5.5 Electronic clinical outcome assessment (eCOA)
5.6 Electronic trial master file (eTMF)
5.7 Electronic data capture (EDC)
5.8 Other solutions
Chapter 6 Market Estimates and Forecast, By Delivery Mode, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Licensed enterprise (on-premise) solutions
6.3 Cloud-based (SAAS) solution (CBS)
6.4 Web-hosted (on-demand) solution (WHS)
Chapter 7 Market Estimates and Forecast, By Clinical Trial Phase, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Phase I
7.3 Phase II
7.4 Phase III
7.5 Phase IV
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Contract research organizations (CROs)
8.3 Medical device companies
8.4 Pharma/biotech companies
8.5 Hospitals and clinics
8.6 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Switzerland
9.3.8 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Thailand
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Argentina
9.5.5 Chile
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Egypt
Chapter 10 Company Profiles
10.1 Acralyon
10.2 Anju Software (OmniComm System)
10.3 Bio-optronics
10.4 Clario
10.5 Dassault Systemes (Medidata)
10.6 Datatrak
10.7 Ennov
10.8 IBM
10.9 Medsharing
10.10 Multihealth Group (Clinfile)
10.11 OpenClinica
10.12 Oracle Corporation
10.13 Parexel International
10.14 Signant Health (CRF Health)
10.15 Veeva Systems
